Clinical trials
Carcinoid Tumor trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 6 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Terminated | 8 |
| Recruiting | 5 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 7 |
| Novartis Pharmaceuticals | 6 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Crinetics Pharmaceuticals Inc. | 2 |
| M.D. Anderson Cancer Center | 2 |
| RayzeBio, Inc. | 2 |
| Rutgers University | 2 |
| SCRI Development Innovations, LLC | 2 |
| Sue O'Dorisio | 2 |
| University of California, San Francisco | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoid Tumor | 64 |
| Neuroendocrine Tumors | 38 |
| Adenoma, Islet Cell | 11 |
| Neoplasm Metastasis | 10 |
| Neoplasms | 8 |
| Serotonin Syndrome | 6 |
| Carcinoma | 5 |
| Carcinoma, Neuroendocrine | 5 |
| Neuroblastoma | 5 |
| Pancreatic Neoplasms | 5 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.